FDA Inspection
CBI Laboratories, Inc. dba Voyant Beauty LLC.CBI Laboratories, Inc. dba Voyant Beauty LLC. – FDA Inspection, May 14, 2019
Record Details
This FDA Inspection record concerns CBI Laboratories, Inc. dba Voyant Beauty LLC., with an inspection on May 14, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d888ea07-479e-4e61-835e-41fe142b6252
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1089889
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.42(c)(1)Incoming material area
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CBI Laboratories, Inc. dba Voyant Beauty LLC.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CBI Laboratories, Inc. dba Voyant Beauty LLC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.